CORDIS · 190199469 · HORIZON

NANOWOUND Antibacterial wound dressing based on advanced nanotechnology to improve the efficiency of wound care

Coordinator: NANORDICA MEDICAL OU (EE)

Infected wounds are a major cause of limb amputations among patients with chronic diseases like diabetes. 10mln amputations occur annually causing €100bln additional healthcare costs. During COVID-19 pandemic the number of amputations rose 10 fold due to low efficacy of current solutions.Nanordica develops an advanced Antibacterial Wound Dressing (AWD) to prevent and treat wound infections. We have demonstrated that our AWD removes bacterial infection 8x better than current best. Our value propositions are high efficacy and low cost.Global antibacterial wound dressing market is projected to r…

EU contribution
€2.4M
Total cost
€3.4M
Period
2023-04-01 → 2026-03-31
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-EIC-ACC-BF
Call
HORIZON-EIC-2022-ACCELERATOR-01
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

Co-funding: the European Union contributes €2.4M toward a total project budget of €3.4M — a funding rate of 70%, with the remainder covered by the consortium partners. The project runs over approximately 3 years from 2023-04-01 to 2026-03-31.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-EIC-ACC-BF funding scheme.
What is the EU contribution?
The European Commission contributes €2.4M toward a total project budget of €3.4M.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call HORIZON-EIC-2022-ACCELERATOR-01.
Who coordinates the project?
The project is coordinated by NANORDICA MEDICAL OU (EE).
What is the project timeline?
The project runs from 2023-04-01 to 2026-03-31 — approximately 3 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 190199469.